These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TAKOTSUBO-LIKE CARDIOMYOPATHY IN A LARGE COHORT OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA. Gagnon N; Mansour S; Bitton Y; Bourdeau I Endocr Pract; 2017 Oct; 23(10):1178-1192. PubMed ID: 28704094 [TBL] [Abstract][Full Text] [Related]
3. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Giavarini A; Chedid A; Bobrie G; Plouin PF; Hagège A; Amar L Heart; 2013 Oct; 99(19):1438-44. PubMed ID: 23837998 [TBL] [Abstract][Full Text] [Related]
6. Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review. Batisse-Lignier M; Pereira B; Motreff P; Pierrard R; Burnot C; Vorilhon C; Maqdasy S; Roche B; Desbiez F; Clerfond G; Citron B; Lusson JR; Tauveron I; Eschalier R Medicine (Baltimore); 2015 Dec; 94(50):e2198. PubMed ID: 26683930 [TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature. Zhang R; Gupta D; Albert SG Int J Cardiol; 2017 Dec; 249():319-323. PubMed ID: 29121733 [TBL] [Abstract][Full Text] [Related]
8. Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma. Wang Y; Yu X; Huang Y Front Endocrinol (Lausanne); 2022; 13():853878. PubMed ID: 35355563 [TBL] [Abstract][Full Text] [Related]
9. Giant Paraganglioma Complicated With Catecholamine Crisis and Catecholamine Cardiomyopathy: A Case Report and Review of the Literature. Ma X; Chen Z; Xia P; Zhang C; Yan K; Fan Y; Wang Y; Ti Y; Bu P Front Endocrinol (Lausanne); 2021; 12():790080. PubMed ID: 35185782 [TBL] [Abstract][Full Text] [Related]
15. A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma. Imperadore F; Azzolini M; Piscioli F; Pusiol T; Capitanio A; Vergara G Ital Heart J; 2002 Jun; 3(6):375-8. PubMed ID: 12116803 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study. Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724 [TBL] [Abstract][Full Text] [Related]
17. Coronary artery myointimal dysplasia in patients with pheochromocytoma-possible causal relationship: pathophysiology and clinical implication with reference to Takotsubo cardiomyopathy and spontaneous coronary dissection. Chow LTC; Chow MBCY Cardiovasc Pathol; 2018; 37():45-53. PubMed ID: 30342321 [TBL] [Abstract][Full Text] [Related]
18. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma. Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma. Lopez C; Bima C; Bollati M; Bioletto F; Procopio M; Arata S; Candela DG; Beccuti G; Ghigo E; Maccario M; Parasiliti-Caprino M Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982228 [TBL] [Abstract][Full Text] [Related]
20. Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review. Wang X; Zhao Y; Liao Z; Zhang Y Front Endocrinol (Lausanne); 2023; 14():1129622. PubMed ID: 37152961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]